A short and concise synthesis of isofagomine, homoisofagomine, and 5′-deoxyisofagomine
摘要:
A short and concise synthesis of isofagomine derivatives via the epoxidation of chiral N-Boc-5-hydroxy-3-piperidene, followed by regioselective epoxide ring opening is described. This constitutes the first reported synthesis of homoisofagomine and the 5'-deoxyisofagomine. (C) 2004 Elsevier Ltd. All rights reserved.
A New Route to Diverse 1-Azasugars from <i>N</i>-Boc-5-hydroxy-3-piperidene as a Common Building Block
作者:Hidekazu Ouchi、Yukiko Mihara、Hiroki Takahata
DOI:10.1021/jo050519j
日期:2005.6.1
for the synthesis of a variety of 1-azasugars with a nitrogen atom at the anomeric position is described. The readily available chiral N-Boc-5-hydroxy-3-piperidene 3 is transformed to isofagomine (2), homoisofagomine (13), and 5‘-deoxyisofagomine (14) via stereoselective epoxidation and regioselective ring-cleavage in a highlystereocontrolled manner. In addition, the synthesis of all four stereoisomers
that, after optimization of the ring-enlargement reaction conditions, could be efficiently transformed into the corresponding 3-hydroxypiperidines. This approach was applied to the asymmetric synthesis of (+)-isofagomine relying on regio- and stereoselective oxirane opening with the cyanide anion of a pivotal epoxypyrrolidine. iminosugar - piperidine - ringenlargement - epoxide opening
The stereoselective preparation of novel C-alkyl 5-membered ring imino sugars and their biological evaluation with regard to GCS inhibition and cytotoxicity in a murine melanoma model are reported.
NEW METHOD FOR PREPARING ISOFAGOMINE AND ITS DERIVATIVES
申请人:Rybczynski Philip
公开号:US20100160638A1
公开(公告)日:2010-06-24
A method for preparing isofagomine, its derivatives, intermediates and salts thereof using novel processes to make isofagomine from D-(−)-arabinose and L-(−)-xylose.
INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE FOR THE TREATMENT OF MOTOR NEURON DISEASES
申请人:Institut du Cerveau et de la Moelle Épinière-ICM
公开号:EP3318277A1
公开(公告)日:2018-05-09
The present invention relates to inhibitors of gangliosides metabolism for treating motor neuron diseases, in particular hereditary spastic paraplegias.